Back to search

Netherlands· NL-6ddf6fe43404

REVAXiS, suspensie voor injectie in een voorgevulde spuit

A diphtherie-poliomyelitis-tetanus product containing difterietoxoïde, geadsorbeerd + poliomyelitis virus type i (mahoney stam) monovalent, geïnactiveerd + poliomyelitis virus type ii (mef-1 stam) monovalent, geïnactiveerd + poliomyelitis virus type iii (saukett stam) monovalent, geïnactiveerd, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 5 of our 19 countries.

ATC J07CA01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedREVAXiS, suspensie voor injectie in e…ATCJ07CA01REGISTER NO.NL-6ddf6fe43404PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Diphtherie-poliomyelitis-tetanus is registered in 5 of 19 countries.

Countries holding a registration under ATC J07CA01 (diphtherie-poliomyelitis-tetanus), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 3 of them publish a price we can compare per daily dose

Diphtherie-poliomyelitis-tetanus · ATC J07CA01

5 / 19 countries

  • Belgiumprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
DIFTERIETOXOÏDE, GEADSORBEERD + POLIOMYELITIS VIRUS TYPE I (Mahoney Stam) MONOVALENT, GEÏNACTIVEERD + POLIOMYELITIS VIRUS TYPE II (MEF-1 Stam) MONOVALENT, GEÏNACTIVEERD + POLIOMYELITIS VIRUS TYPE III (Saukett Stam) MONOVALENT, GEÏNACTIVEERD
Manufacturer
Euro Registratie Collectief B.V.
Country
Netherlands (NL)
ATC code
J07CA01
ATC class
Diphtherie-Poliomyelitis-Tetanus
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    126102//24534

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d472577d-5477-40ef-857b-ed8bdcc2f16e
GET /v1/drugs/d472577d-5477-40ef-857b-ed8bdcc2f16e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspensie voor injectie",
  "route": "Intramusculair gebruik, Subcutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h24534_smpc.pdf",
  "strength": null,
  "atc_label": "Diphtheria-Poliomyelitis-Tetanus",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg126102",
  "excipients": [
    "ALUMINIUMHYDROXIDE, GEHYDRATEERD, VOOR ADSORPTIE",
    "AZIJNZUUR (E 260)",
    "FENOXYETHANOL",
    "FORMALDEHYDE",
    "MULTI-COMPONENT MEDIUM 199",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "DIFTERIETOXOÏDE, GEADSORBEERD",
    "POLIOMYELITIS VIRUS TYPE I (Mahoney Stam) MONOVALENT, GEÏNACTIVEERD",
    "POLIOMYELITIS VIRUS TYPE II (MEF-1 Stam) MONOVALENT, GEÏNACTIVEERD",
    "POLIOMYELITIS VIRUS TYPE III (Saukett Stam) MONOVALENT, GEÏNACTIVEERD",
    "TETANUSTOXOÏDE, GEADSORBEERD, GEINACTIVEERD"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h126102.pdf",
  "authorised_at": "2020/05/04",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "126102//24534",
  "additional_monitoring": "N"
}

See everything about diphtherie-poliomyelitis-tetanus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.